Please assess the completion status of the following clinical trial:

Trial Title: Diabetes Prevention Program

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Impaired glucose tolerance (fasting plasma glucose 95-125 mg/dL and 2hr plasma glucose 140-199 mg/dL)~* BMI \>= 24 kg/m2~Exclusion Criteria:~* Underlying disease likely to limit life span and/or increase risk of interventions~* Conditions or behaviors likely to effect conduct of the DPP~* Diabetes or disordered glucose metabolism~* Suboptimally treated Thyroid disease~* Fasting triglyceride level \< 600 mg/dl~* Exclusions related to medications

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): None
- Metformin (Type: ACTIVE_COMPARATOR): None
- Intensive Lifestyle (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).